Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography

References

• Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246–55.
   PubMed Web of Science ®Google Scholar
• Steele R, Hudson M, Lo E, Baron M; Canadian Scleroderma Research Group. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res (Hoboken) 2012;64:519–24.
   PubMed Web of Science ®Google Scholar
• Fischer A, Swigris JJ, Groshong SD, Cool CD, Sahin H, Lynch DA, et al. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest 2008;134:601–5.
   PubMed Web of Science ®Google Scholar
• Afeltra A, Zennaro D, Garzia P, Gigante A, Vadacca M, Ruggiero A, et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high–resolution computed tomography. Scand J Rheumatol 2006;35:388–94.
   PubMed Web of Science ®Google Scholar
• Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, et al. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med 2010;182:252–60.
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62:D42–50.
   PubMed Web of Science ®Google Scholar
• Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SG, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Resp Crit Care Med 2008;177:1248–54.
   PubMed Web of Science ®Google Scholar
• Hunninghake GW, Zimmerman MB, Schwartz DA, King TE Jr, Lynch J, Hegele R, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193–6.
   PubMed Web of Science ®Google Scholar
• Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, Black CM, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:738–42.
   PubMed Web of Science ®Google Scholar
• Schneider F, Gruden J, Tazelaar HD, Leslie KO. Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med 2012;136:1242–52.
   PubMed Web of Science ®Google Scholar
• Fischer A, Bull TM, Steen VD. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension. Arthritis Care Res (Hoboken) 2012;64:303–10.
   PubMed Web of Science ®Google Scholar
• Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron PY. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 1993;188:499–506.
   PubMed Web of Science ®Google Scholar
• Nihtyanova SI, Schreiber BE, Ong VH, Rosenberg D, Moinzadeh P, Coghlan JG, et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 2014; 66:1625–35.
   PubMed Web of Science ®Google Scholar
• van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65:2737–47.
   PubMed Web of Science ®Google Scholar
• Hansell DM. Classification of diffuse lung diseases: why and how. Radiology 2013;268:628–40.
   PubMed Web of Science ®Google Scholar
• Patiwetwitoon S, Wangkaew S, Euathrongchit J, Kasitanon N, Louthrenoo W. High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis. J Clin Rheumatol 2012;18:229–33.
   PubMed Web of Science ®Google Scholar
• Sperandeo M, Rotondo A, Guglielmi G, Catalano D, Feragalli B, Trovato GM. Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: use and limitations. Radiol Med 2014;119:729–40.
   PubMed Web of Science ®Google Scholar
• Sperandeo M, Varriale A, Sperandeo G, Filabozzi P, Piattelli ML, Carnevale V, et al. Transthoracic ultrasound in the evaluation of pulmonary fibrosis: our experience. Ultrasound Med Biol 2009;35:723–9.
   PubMed Web of Science ®Google Scholar
• Cassanelli N, Caroli G, Dolci G, Dell’Amore A, Luciano G, Bini A, Stella F. Accuracy of transthoracic ultrasound for the detection of pleural adhesions. Eur J Cardiothorac Surg 2012;42:813–18.
   PubMed Web of Science ®Google Scholar
• Sperandeo M, Trovato GM, Catalano D. Quantifying B-lines on lung sonography: insufficient evidence as an objective, constructive, and educational tool. J Ultrasound Med 2014; 33:362–5.
   PubMed Web of Science ®Google Scholar
• Trovato GM, Sperandeo M. Sounds, ultrasounds, and artifacts: which clinical role for lung imaging? Am J Respir Crit Care Med 2013;187:780–1.
   PubMed Web of Science ®Google Scholar
• American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003;16:1091–110.
   PubMed Web of Science ®Google Scholar
• Hesselstrand R, Scheja A, Wuttge DM, Arheden H, Ugander M. Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease. Scand J Rheumatol 2011;40:133–8.
   PubMed Web of Science ®Google Scholar
• Miller L, Chartrand S, Koenig M, Goulet JR, Rich É, Chin AS, et al. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort. Scand J Rheumatol 2014;43:314–23.
   PubMed Web of Science ®Google Scholar
• Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, et al. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group. Arthritis Rheum 2011;63:3078–85.
   PubMed Web of Science ®Google Scholar
• Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin DP, Goldin JG, et al. Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease. Arthritis Rheum 2011;63:2797–808.
   PubMed Web of Science ®Google Scholar
• Zanforlin A, Smargiassi A, Inchingolo R, Sher S, Ramazzina E, Corbo GM, et al. B-lines: to count or not to count? JACC Cardiovasc Imaging 2014;7:635–6.
   PubMed Web of Science ®Google Scholar
• Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 2005;52:2125–32.
   PubMed Web of Science ®Google Scholar
• Le Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, et al. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. Arthritis Rheum 2011;63:2456–64.
   PubMed Web of Science ®Google Scholar
• Trovato GM, Sperandeo M, Catalano D. Thoracic ultrasound: possible complementary criteria for the assessment of pulmonary fibrosis. Ann Thorac Med 2014;9:179.
   PubMed Web of Science ®Google Scholar
• Saketkoo LA, Mittoo S, Frankel S, Lesage D, Sarver C, Phillips K, et al. Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases. J Rheumatol 2014;41:792–8.
   PubMed Web of Science ®Google Scholar
• Frauenfelder T, Winklehner A, Nguyen TD, Dobrota R, Baumueller S, Maurer B, et al. Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study. Ann Rheum Dis 2014;73:2069–73.
   PubMed Web of Science ®Google Scholar
• Nihtyanova SI, Schreiber BE, Ong VH, Rosenberg D, Moinzadeh P, Coghlan JG, et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 2014; 66:1625–35.
   PubMed Web of Science ®Google Scholar